Home › Funds › Tri Locum Partners LP › UTHR
Tri Locum Partners LP position in UTHR
UNITED THERAPEUTICS CORP DEL · Health Care
Tri Locum Partners LP reported holding 47,026 shares of UTHR (UNITED THERAPEUTICS CORP DEL) in its Q2 2026 13F filing — a position valued at US$25.5M, representing 3.13% of its reported portfolio and ranking #12 among its reported holdings. Tri Locum Partners LP has disclosed UTHR holdings in 6 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Tri Locum Partners LP's UTHR position evolved
Tri Locum Partners LP first disclosed a stake in UTHR in Q2 2024 at 50,100 shares (US$16.0M). The position peaked in Q4 2025 at 120,921 shares, worth US$58.9M. Across 6 filings, Tri Locum Partners LP increased the stake 1 time(s), trimmed it 3 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 47,026 shares valued at US$25.5M — a reduction of -23,344 shares quarter over quarter.. Notable position changes include a 42% trim in Q1 2026 (shares fell 9% over the following quarter), a 33% trim in Q2 2026 (shares were roughly flat over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 50.10K | $15.96M | New |
| Q3 2024 | 54.93K | $19.68M | Add |
| Q3 2025 | 122.19K | $51.22M | New |
| Q4 2025 | 120.92K | $58.92M | Reduce |
| Q1 2026 | 70.37K | $41.73M | Reduce |
| Q2 2026 | 47.03K | $25.48M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UTHR and 13F data
UTHR (UNITED THERAPEUTICS CORP DEL) is a Health Care company. 43 other funds we track also report a position in UTHR — the largest reported positions include Avoro Capital Advisors LLC (US$1.51B), Renaissance Technologies (US$925.8M), ASSETMARK, INC (US$338.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UTHR
- Avoro Capital Advisors LLC 2.78M sh · $1.51B · Q2 2026
- Renaissance Technologies 1.71M sh · $925.85M · Q2 2026
- ASSETMARK, INC 624.07K sh · $338.14M · Q2 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 457.00K sh · $247.62M · Q2 2026
- Vestal Point Capital, LP 435.00K sh · $235.70M · Q2 2026
- Eversept Partners, LP 287.67K sh · $155.87M · Q2 2026
More on Tri Locum Partners LP
FAQ
How long has Tri Locum Partners LP held UTHR?
Tri Locum Partners LP has disclosed UTHR holdings in 6 of the last 9 reported quarters, going back to Q2 2024.
What is Tri Locum Partners LP's current position in UTHR?
As of Q2 2026, Tri Locum Partners LP holds 47.03K shares of UTHR (UNITED THERAPEUTICS CORP DEL), valued at $25.48M, representing 3.13% of its reported portfolio and ranking #12.
Has Tri Locum Partners LP been buying or selling UTHR?
In the latest 13F filing (Q2 2026), Tri Locum Partners LP reduced its position in UTHR. The position peaked in Q4 2025 at 120.92K shares.
Which other funds hold UTHR?
Other major institutional holders of UTHR include Avoro Capital Advisors LLC, Renaissance Technologies, ASSETMARK, INC, among 43 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.